RHEACEL is a subsidiary of TICEBA, developing human pharmaceuticals based on ABCB5+ mesenchymal stem cells. The company uses the GMP-compliant manufacturing process established by TICEBA to expand primary limbal stem cells from corneal tissue donors. Clinical trials using these cells are ongoing in Germany and the US.
Timeline
2012
RHEACELL was founded by Christoph Ganss.
Patents
Further Resources
Title
Author
Link
Type
Date
References
4
Type: Web page
https://www.rheacell.com/en/team/5
Type: Web page
https://www.rheacell.com/en/team/
Organization
CompanyCompany attributes
Biotechnology
Stem cell
MSC (Mesenchymal Stromal Cell)Location
HeidelbergCompany Operating Status
Active
CEO
Founder
Pitchbook URL
Date Incorporated
2012
Full Address
Im Neuenheimer Feld 517 69120 Heidelberg, Germany
Founded Date
2012
Email Address
office@rheacell.com
Phone Number
+496221718330
Other attributes
Country
GermanyCategories
Related Topics
Contributors
- 1
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 2
Duzenko Andrey
Extensive experience in development and interaction with the community - 3
Dawson Sewell
Writing about startups. - 4
Seotaek Lee
interested in web3 - 5
Mark Simonov
Hi. I'm a sales manager. I like to read classics and fantasy - 6
Ольга Дрокина
chef - 7
Katrina-Kay Pettitt
Data Duchess @ Golden - 8
Rahul Goyal
Researcher - 9
Rebecca Hammond
MA English I HDip Psychology - Following AI, behavioural and educational psychology
